COVID-19 vaccination and breakthrough infections in patients with cancer

Schmidt, Andrew; Labaki, Chris; Hsu, Chih–Yuan; Bakouny, Ziad; Balanchivadze, Nino; Berg, Stephanie; Blau, Sibel; Daher, Ahmad; El Zarif, Talal; R. Friese, Christopher; A. Griffiths, Elizabeth; E. Hawley, Jessica; Hayes‐Lattin, Brandon; Karivedu, Vidhya; Latif, Tahir; H. Mavromatis, Blanche; R. McKay, Rana; Nagaraj, Gayathri; H. Nguyen, Ryan; A. Panagiotou, Orestis; J. Portuguese, Andrew; Puc, Matthew; Santos Dutra, Míriam; Schroeder, Brett; Thakkar, Astha; Wulff‐Burchfield, Elizabeth; Mishra, Sanjay; Farmakiotis, Dimitrios; Shyr, Yu; L. Warner, Jeremy; K. Choueiri, Toni; K. Choueiri, Toni; Duma, Nathan; Farmakiotis, Dimitrios; Grivas, Petros; Lopes, Gilberto; Painter, Corrie; Peters, Solange; I. Rini, Brian; P. Shah, Dimpy; Thompson, Michael; L. Warner, Jeremy

doi:10.1016/j.annonc.2021.12.006

Public

COVID-19 vaccination and breakthrough infections in patients with cancer

Published in Annals of Oncology • Dec 24, 2021

Authors:

Andrew Schmidt

Chris Labaki

Chih–Yuan Hsu

Abstract

BACKGROUND: Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of antineoplastic systemic therapies can result in less robust antibody titers following vaccination and pos...

Subject

Medicine

Vaccination

Cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!